Adaptin Bio, Inc. Stock-Based Compensation
Adaptin Bio, Inc. (APTN) reported Stock-Based Compensation of $539.20 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-28
- Adaptin Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $193.81K.
- Adaptin Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $345.40K.
- Adaptin Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $176.74K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $193.81K derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | $539.20K S-1 · filed 2026-08-28 | $715.94K derived: sum of 3 quarters · filed 2026-08-28 | |
| 2026-03-31 | $345.40K POS AM · filed 2026-07-21 | $522.13K derived: sum of 2 quarters · filed 2026-08-28 | ||
| 2025-12-31 | $176.74K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | $496.86K S-1 · filed 2026-08-28 | ||
| 2025-09-30 | $320.13K 10-Q · filed 2025-11-14 |